linked vallum investor relations chicago

LINKED VALLUM INVESTOR RELATIONS CHICAGO FULL

Elterman: What are the cost differences?Ī. Also, my patients say, “I hated the catheter, but I'm so thankful I did this procedure.” If the expectations are set, I find my patients are willing to put up with the catheter for a few days, maybe a few weeks of some irritative symptoms. Fagelson: I think once they see how easy it is, whether they've adopted UroLift or not, I think they'll start moving over to doing Rezūm Therapy. *NOTE: Dependent on individual clinical situation and healing response.

LINKED VALLUM INVESTOR RELATIONS CHICAGO FULL

Once the catheter comes out in a week, they're back to full activity.* I’ve done over 40 patients and I've had no major side effects, no retreatments. Golio: Positive patient outcomes – patients are coming back happy after Rezūm Therapy, they're doing very well. If you would tell me that I can take care of a patient and only 4.4% of them might need surgery again, and 11.1% 1 of them might need medications again, I don't see what else could be more convincing than that.ĭr. Cohen: The Rezūm Therapy procedure works well, seems to cause fewer side effects, compared to those typically seen with surgical therapies, costs less to patients than other MITs or surgical therapies and it's easy to do it right there in the office. Elterman: Can you tell us about your initial experience with UroLift?ĭr. Dean Elterman, Assistant Professor, University of Toronto and Attending Urologist, University Health Network, Toronto, Canada, moderated a virtual roundtable discussion with four other urologists to explore their experiences with the UroLift System and Rezūm Therapy. Both procedures have long-term durability data up to five years. Rezūm Therapy is an in-office, minimally invasive procedure that uses water vapor thermal therapy (steam) to shrink the prostate. The UroLift System is an in-office, minimally invasive solution that involves the use of implants to hold open the obstructed pathway that’s blocking urine flow. Two MITs have recently come into prominence: UroLift™ Prostatic Urethral Lift System and Rezūm™ Water Vapor Therapy. When it comes to minimally invasive treatment (MIT) for benign prostatic hyperplasia (BPH), urologists are looking not only for good short-term results but also for long-term durability. Physician experience and patient responses can and do vary. Elterman, Fagelson, Cohen and Golio are Boston Scientific consultants and were compensated. The sentiments expressed within this article are representative of the opinions and experiences of the respective physicians. Medical Device ID Cards - Pacemaker, ICD, & CRT devices.Transcatheter Aortic Valve Replacement (TAVR).

Cardiac Resynchronization Therapy (CRT) Devices.

Other provisions, such as the creation of tiered licensing fees, would be implemented April 1, 2021. That part of the ordinance, along with a measure to give the city increased authority to prohibit house parties, would go into effect October 17. [Update: The Chicago City Council unanimously approved an ordinance Wednesday that bans single-night stays in short-term rentals in the city. In the run-up to the vote on the measure, which was adopted in committee last month, Airbnb emailed hosts, urging them to communicate to elected officials 'how this bill may negatively impact your ability to earn extra income.' If you are in Airbnb's virtual bunker trying to set up an initial public offering, consider what it must be like coping with almost-daily headlines about house parties gone wild or regulatory setbacks that interfere with a more positive story.Ī case in point on the regulatory front is Chicago, where the city council is slated to vote Wednesday on an ordinance that would ban single-night stays in short-term rentals.

Linked vallum investor relations chicago